DURATION ADJUSTMENTS IN SCHEDULED REDUCED SMOKING

二十年来，戒烟行为疗法的发展已经被药理学方法所取代。个人计算机化设备的出现重新引起了人们对行为方法的兴趣。在监测使用情况、量身定做治疗方法、提供复杂的治疗方案和提供即时反馈方面取得了很大进展。事实证明，在使用科技设备的情况下，按计划减少吸烟是非常有效的。然而，在基线收集周之后，开创性的对照研究采用了21天的三阶段递减方案。这种一刀切、任意派生的协议，当它适应不同的细微差别时，可能会显示出更大的效率。这项研究将测试一种调整这种备受推崇的疗法的治疗持续时间的技术。该策略比较用户对预定方案的遵从性，并进行每周一次的中期纠正，考虑与计划的偏差。我们的计算机化交互通信器专为执行减少算法而设计，将成为该养生法的传输系统。该设备显著提高了使用数据收集、档案准确性、个性化敏感性和方案定制的标准。拟议的商业应用：该仪器将作为一种非处方戒烟疗法(L)上市，作为一种高效的自助最低接触行为疗法替代疗法，(2)作为其他行为、药物和尼古丁替代疗法的辅助疗法；以及(3)作为更准确地记录烟草使用、吸烟者类型和治疗依从性的研究工具。

Development of behavioral therapies for smoking cessation has been superseded by pharmacological approaches for two decades. The advent of personal computerized devices has ushered in a resurgence of interest in behavioral approaches. Great advances have been made in monitoring usage, tailoring treatments, delivering complex regimens, and giving instantaneous feedback. Scheduled smoking reduction proved highly efficacious when executed with technological devices. Pioneering controlled studies, however, employed a three-stage step-down regimen of 21 days, following baseline collection week. This one-size-fits-all, arbitrarily derived protocol may show even greater effectiveness when it adapts to individual nuances. This study will test a technique for adjusting treatment durations for that highly regarded therapy. The strategy compares users' compliance with scheduled regimens and conducts weekly mid-course corrections that consider deviation from the plan. Uniquely designed to perform reduction algorithms, our computerized interactive communicator will be the delivery system for this regimen. The device significantly raises the standards for usage data collection, profile accuracy, personalized sensitivity and regimen tailoring. PROPOSED COMMERCIAL APPLICATION: This instrument will be commercially marketed for use as an over-the- counter stop-smoking therapy (l) as a highly-effective self-help minimum contact behavioral treatment alternative, (2) as an adjunct to other behavioral, pharmacological, and nicotine replacement therapies; and (3) as a research tool to more precisely record tobacco usage, smoker typology, and treatment compliance.